Notice to the reader: This document has been updated by an advisory dated December 18, 2008.
Advisory
2007-147
October 11, 2007
For immediate release
OTTAWA - Concerns have been raised regarding the safety of "over-the-counter" (non-prescription) cough and cold products in children. Health Canada is advising consumers on the appropriate use of these products, including drugs and natural health products, particularly in children under 2 years of age. Life-threatening adverse events, including unintentional overdose, have been reported to Health Canada in association with the use of these products in children under 2 years of age.
There are more than 700 authorized non-prescription cough and cold products marketed in Canada. The Department is in the process of determining if the labelling of these products is sufficient to ensure that parents, caregivers and prescribers have all the information needed to make an informed decision concerning the safe use of these products.
Before using over-the-counter cough and cold remedies in children under 2 years of age, Health Canada urges caregivers to consult a healthcare practitioner to assure that their use is safe and appropriate. In addition, Health Canada strongly advises parents and caregivers to carefully read the labels and instructions for these products and to check the medicinal ingredients before giving them to any child, especially under the age of 2. Many of these products contain the same medicinal ingredient(s), and giving more than one product with the same ingredient or multiple doses of the same product could lead to an overdose.
Special attention should also be given when using cough and cold products at the same time as medications sold over the counter to control fever (for example, acetaminophen or ibuprofen), in order to avoid exposing children to excessive doses of these medications, since some cough and cold products also contain these medicinal ingredients.
Important Recommendations
Children under 2 years of age
Children of all ages
Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at (613) 957-2991, or toll free at 1-866-225-0709.
To report a suspected adverse reaction to these health products, please contact the Canada Vigilance Program of Health Canada by one of the following methods:
Telephone: 1-866-234-2345
Facsimile: 1-866-678-6789
Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, Ontario, AL 0701C
K1A 0K9
E-mail: CanadaVigilance@hc-sc.gc.ca
The Canada Vigilance adverse reaction reporting form, including a version that can be completed and submitted online, is located in the MedEffect area of the Health Canada Web site.
-30-
Media Enquiries:
Paul Duchesne
Health Canada
(613) 954-4807
Public Enquiries:
(613) 957-2991
1-866 225-0709